RELN and Alzheimer disease: ApoE4, the strongest genetic risk factor for late-onset AD, interferes with ApoER2 recycling, reduces receptor surface expression, and diminishes Reelin's ability to phosphorylate Dab1 and stabilize glutamate receptors (Chen et al., 2010).